About this trial
Primary PC - or training HCT clinicians to deliver PC domains as part of routine practice - is an alternative model of supportive care. We have developed Sentinel, a primary PC intervention for HCT clinicians and patients. This study will assess Sentinel's feasibility and acceptability.
Eligibility criteria
Qualifiers
Age 18 years or older
Undergoing autologous or allogeneic HCT at MGH
Disqualifiers
Prior receipt of inpatient specialty palliative care on two prior admissions in the past 6 months.
Significant uncontrolled psychiatric disorders (psychotic disorder, bipolar disorder, major depression) or other co-morbid disease (dementia, cognitive impairment), which the primary oncologist believes prohibits informed consent or ability to participate in study procedures
Inability to comprehend English as this is a preliminary/pilot study
Trial design
Treatments tested in this trial
- Primary palliative care
Treatment groups
Sponsors and collaborators
Massachusetts General Hospital
Lead sponsor
American Society of Transplantation and Cellular Therapy
Collaborator